Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis. | |||
Novartis Patient Assistance Foundation, Inc. (NPAF)This program provides medication at no cost. @if> |
|||
Provided by: Novartis Pharmaceuticals Corporation |
|||
PO Box 52029 TEL: 800-277-2254FAX: 855-817-2711 |
Languages Spoken:
English, Others By Translation Service |
||
Program Applications and Forms |
|||
Novartis Patient Assistance Foundation, Inc. Enrollment Application: Contact program |
|||
Medications |
|||
|
|||
Eligibility Requirements |
|||
Insurance Status | Contact program for details. | ||
Those with Part D Eligible? | Contact program for details. | ||
Income | Based on FPL | ||
Diagnosis/Medical Criteria | Not specified | ||
US Residency Required? | Must be residing in the US or US territory | ||
Application |
|||
Obtaining | Call or download | ||
Receiving | Faxed | ||
Returning | Fax or mail | ||
Doctor's Action | Complete section, sign, attach required documents | ||
Applicant's Action | Complete section, sign, attach required documents | ||
Decision Communicated | Patient and Doctor are notified | ||
Decision Timeframe | Not specified | ||
Medication |
|||
Amount/Supply | Varies | ||
Sent To | Patient's home, unless otherwise noted | ||
Delivery Time | Not specified | ||
Refill Process | Contact program for details. | ||
Limit | Not specified | ||
Re-application | New application, new documentation yearly | ||
Additional Information |
|||
Novartis Oncology Products: To start the application process apply to PANO (Patient Assistance Now Oncology) at www.patient.novartisoncology.com or (800) 282-7630. Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Mayzent: To start the application process apply to Alongside™ Mayzent at www.Mayzent.com or (877) 629-9368. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com |
|||
Updated March 20, 2023 |